DK2961413T3 - Selamectin til behandling af havluseinfestationer - Google Patents

Selamectin til behandling af havluseinfestationer Download PDF

Info

Publication number
DK2961413T3
DK2961413T3 DK14708777.9T DK14708777T DK2961413T3 DK 2961413 T3 DK2961413 T3 DK 2961413T3 DK 14708777 T DK14708777 T DK 14708777T DK 2961413 T3 DK2961413 T3 DK 2961413T3
Authority
DK
Denmark
Prior art keywords
selamectin
treatment
sea lice
lice infestations
infestations
Prior art date
Application number
DK14708777.9T
Other languages
English (en)
Inventor
John Adam Wendt
David Jose Asper
Stacy Ross
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50238514&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2961413(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Application granted granted Critical
Publication of DK2961413T3 publication Critical patent/DK2961413T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/163Sugars; Polysaccharides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/80Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81Aquaculture, e.g. of fish
    • Y02A40/818Alternative feeds for fish, e.g. in aquacultures

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Insects & Arthropods (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Farming Of Fish And Shellfish (AREA)
DK14708777.9T 2013-02-26 2014-02-26 Selamectin til behandling af havluseinfestationer DK2961413T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361769484P 2013-02-26 2013-02-26
PCT/US2014/018506 WO2014134101A1 (en) 2013-02-26 2014-02-26 Selamectin for treatment of sea lice infestations

Publications (1)

Publication Number Publication Date
DK2961413T3 true DK2961413T3 (da) 2020-09-07

Family

ID=50238514

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14708777.9T DK2961413T3 (da) 2013-02-26 2014-02-26 Selamectin til behandling af havluseinfestationer

Country Status (14)

Country Link
US (1) US10765657B2 (da)
EP (1) EP2961413B1 (da)
CN (1) CN105101973A (da)
AR (1) AR094882A1 (da)
AU (1) AU2014223626A1 (da)
BR (1) BR112015020342A2 (da)
CA (1) CA2900950C (da)
CL (1) CL2015002329A1 (da)
DK (1) DK2961413T3 (da)
HK (1) HK1215676A1 (da)
NZ (1) NZ710522A (da)
PE (1) PE20151753A1 (da)
RU (1) RU2015133445A (da)
WO (1) WO2014134101A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2560882A (en) * 2017-03-15 2018-10-03 Preston Innovations Ltd Fish bait additive

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
GB9024928D0 (en) * 1990-11-16 1991-01-02 Beecham Group Plc Novel treatment
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
US5981500A (en) 1994-01-12 1999-11-09 Pfizer Inc. Antiparasitic agents related to the milbemycins and avermectins
GB9825402D0 (en) 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
US6486128B1 (en) * 1999-04-08 2002-11-26 Schering-Plough Veterinary Corporation Method of using emamectin to treat fish parasites
US6538031B1 (en) 1999-11-25 2003-03-25 Novartis Animal Health Us, Inc. Method of controlling sea lice infestation in fish
CA2620440C (en) 2005-08-29 2014-01-28 Novartis Ag Use of oxazole derivatives for controlling fish parasites
EP1849363A1 (en) * 2006-03-09 2007-10-31 Cheminova A/S Synergistic combination of glutamate- and GABA-gated chloride agonist pesticide and at least one of Vitamin E or Niacin
BRPI0705822A2 (pt) * 2007-10-25 2009-06-23 Schering Plough Saude Animal Ltda formulação injetável com ação prolongada e uso de um agente semi-sintético derivado do grupo das avermectinas, em combinação com um polìmero biodegradável
CN103270036B (zh) * 2010-08-05 2015-11-25 佐蒂斯有限责任公司 作为抗寄生物剂的异噁唑啉衍生物
CN102406074A (zh) * 2011-11-18 2012-04-11 大连兆阳软件科技有限公司 一种鱼饲料

Also Published As

Publication number Publication date
CA2900950A1 (en) 2014-09-04
EP2961413A1 (en) 2016-01-06
BR112015020342A2 (pt) 2017-07-18
NZ710522A (en) 2016-05-27
WO2014134101A1 (en) 2014-09-04
HK1215676A1 (zh) 2016-09-09
AR094882A1 (es) 2015-09-02
PE20151753A1 (es) 2015-12-02
RU2015133445A (ru) 2017-03-31
CN105101973A (zh) 2015-11-25
US10765657B2 (en) 2020-09-08
US20150366837A1 (en) 2015-12-24
EP2961413B1 (en) 2020-08-05
AU2014223626A1 (en) 2015-08-20
CL2015002329A1 (es) 2016-01-08
CA2900950C (en) 2017-06-27

Similar Documents

Publication Publication Date Title
BR112017018843A2 (pt) combinações de composto fungicidamente ativo
FR3034146B1 (fr) Mousqueton
DK2968208T3 (da) Behandling af kataplexi
DK2954051T3 (da) Modificeret kapsid til genoverførsel til behandling af nethinden
DK2964315T3 (da) System til behandling af neuromotorisk dysfunktion
DK3035802T3 (da) Kontrolleret vækst af mikroorganismer
DK3010895T3 (da) Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
DK3016493T3 (da) Behandling til desinficering af frø
KR20180084915A (ko) 구조체
BR112017005883A2 (pt) compostos herbicidas
BR112017017193A2 (pt) compostos herbicidas
BR112017013013A2 (pt) combinações de composto ativo
BR112016030730A2 (pt) Composto
BR112016029117A2 (pt) compostos herbicidas
FI20145185A (fi) Liikkeenrajoitinrakenne
DK3347403T3 (da) Polyalkoxyfedtforbindelse
BR112016003583A2 (pt) compostos herbicidas
DK2976101T3 (da) Behandlingsfremgangsmåde
CL2016000616A1 (es) Compuestos heterocíclicos de n-acilimino.
FR3035563B1 (fr) Arrosage autonome-telegere
DK3082860T3 (da) Fremgangsmåde til behandling af sår
DE112016001834A5 (de) Kanüle
DK2968281T3 (da) Mtor-hæmmere til forebyggelse af vækst af tarmpolyp
DK2961413T3 (da) Selamectin til behandling af havluseinfestationer
ES1079038Y (es) Trampa selectiva de avispas